Moderna | MRNA - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 209.65B 14.21B 2026-08
Arrowhead Research USD 10.84B 664M 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Cspc Pharmaceutical CNY 99.86B 3.93B 2026-08
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 4.58B 2.8B 2026-03
Divis Laboratories Ltd INR 2.21T 464.84B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Incyte USD 26.84B 4.19B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 133.52M 29.05M 2026-08
Organigram Holdings CAD 252.47M 59.69M 2026-03
Ovoca Bio EUR 5.1M 3.93M 2026-08
Pharma Mar EUR 1.39B 78.26M 2026-08
Qiagen NV USD 8.47B 396.81M 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Sartorius EUR 15.63B 1.38B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
United Therapeutics USD 24.42B 1.42B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08
Zealand Pharma A/S 33.35B 12.51B 2026-08